Used as a key intermediate in the synthesis of fluorinated pharmaceuticals and agrochemicals, particularly in the development of selective kinase inhibitors. Its structure enables efficient introduction of the 5-fluoro-2-nitrobenzyl protecting group, which is valuable in peptide and nucleotide chemistry due to its sensitivity to mild oxidative or reductive conditions. Commonly employed in solid-phase synthesis and prodrug design where controlled release of active compounds is required. Also utilized in the preparation of specialty polymers and labeled compounds for metabolic studies.